While CD4+ Tregs have been extensively studied, the lack of universal markers to distinguish CD8+ Treg cells from conventional CD8+ T cells means that the function of CD8+ Tregs in cancer remains undefined [61]. The gene discussed is CD8A; the disease is cancer.